Cofoe Medical Technology Co

Cofoe Medical Technology Co EBIT per Share

The EBIT per Share of Cofoe Medical Technology Co (301087.SZ) as of Oct 23, 2026 is 1.89 CNY. In the previous year, EBIT per Share was 1.73 CNY — a change of 9.49% (higher).

EBIT per Share

1.89CNY

YoY

9.49%

Last updated:

EBIT per Share of Cofoe Medical Technology Co is 2025 1.89 CNY. EBIT per Share of Cofoe Medical Technology Co was 2024 1.73 CNY. It decreases by 9.49% higher compared to the previous year.

The Cofoe Medical Technology Co EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2020
2.52 CNY
Jan 1, 2021
2.52 CNY
Jan 1, 2022
1.58 CNY
Jan 1, 2023
1.33 CNY
Jan 1, 2024
1.73 CNY
Jan 1, 2025
1.89 CNY
Jan 1, 2026 (e)
2.55 CNY
Jan 1, 2027 (e)
2.96 CNY
The Cofoe Medical Technology Co EBIT per Share history
YEAREBIT per ShareYoY
est2.96CNY+16.32%
est2.55CNY+34.56%
1.89CNY+9.49%
1.73CNY+30.20%
1.33CNY-15.71%
1.58CNY-37.48%
2.52CNY+0.00%
2.52CNY+209.14%
0.82CNY+105.76%
0.40CNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cofoe Medical Technology Co Stock analysis

What does Cofoe Medical Technology Co do? Cofoe Medical Technology Co., Ltd. generates revenue through the research, development, manufacture, and sale of medical equipment under the Cofoe brand. The company offers products such as blood pressure monitors, infrared thermometers, nursing beds, wheelchairs, nebulizers, moxibustion series, and health protection supplies. These products cater to domestic and overseas markets, serving segments including health monitoring, rehabilitation aids, medical care, traditional Chinese medicine physiotherapy, and respiratory support. The firm's domestic market presence and international sales drive its revenue streams. The company's product portfolio includes health monitoring devices, rehabilitation aids, medical care equipment, traditional Chinese medicine physiotherapy tools, and respiratory support systems. These are sold under the Cofoe brand to both domestic and overseas customers. The firm's focus on traditional Chinese medicine physiotherapy and respiratory support systems differentiates its offerings in the medical equipment sector. Cofoe's domestic market operations and overseas business expansion contribute to its overall revenue. Cofoe Medical Technology Co., Ltd. targets customers seeking health monitoring, rehabilitation, medical care, and traditional Chinese medicine physiotherapy solutions. Its domestic market segment includes hospitals, clinics, and individual consumers, while overseas markets extend to international healthcare providers and consumers. The company's product range, from blood pressure monitors to moxibustion series, supports these segments with specialized medical equipment. Cofoe Medical Technology Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Cofoe Medical Technology Co stock

EBIT per Share of Cofoe Medical Technology Co is 1.89 CNY in 2025.

EBIT per Share of Cofoe Medical Technology Co changed from 1.73 CNY to 1.89 CNY, representing a 9.49% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Share Cofoe Medical Technology Co since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Cofoe Medical Technology Co

All Key Metrics — Cofoe Medical Technology Co